Ariston, Irwin M.

HRN: 26-05-55  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/10/2025
06/17/2025
IV
600mg
Q8
Buerger’s Disease
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: